tiletamine hydrochloride has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buitrago-Molina, LE; Cañón, JM; Finegold, M; Geffers, R; Grompe, M; Lamlé, J; Manns, MP; Marhenke, S; Sporn, M; Vogel, A; Yamamoto, M | 1 |
| Hosaka, Y; Kato, K; Mochizuki, H; Muramatsu, H; Nagata, S; Nakamura, N; Nakayama, K; Ohmori, Y; Saitoh, F; Takiguchi, K; Tsuda, T | 1 |
2 other study(ies) available for tiletamine hydrochloride and Hepatitis
| Article | Year |
|---|---|
Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
Topics: Animals; Cyclohexanones; DNA Damage; Dose-Response Relationship, Drug; Glutathione; Hepatitis; Hydrolases; Imidazoles; Inactivation, Metabolic; Liver; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Mice; Mice, Knockout; NF-E2-Related Factor 2; Nitrobenzoates; Oleanolic Acid; Oxidative Stress; Tyrosinemias | 2008 |
Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia.
Topics: Alopecia; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; COS Cells; Cyclohexanones; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; Female; Hepatitis; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; U937 Cells | 2001 |